drugset / Trial / NCT00655083
A Phase I Study to Evaluate the Oral Absorption of Nepadutant in Infants
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of the study is to evaluate the gastrointestinal absorption of nepadutant after single dose as oral solution (and the effect of age on its oral absorption) in infants. Oral absorption is evaluated through the drug recovery in urine.
Timeline
- Start
- 2008-03
- Primary completion
- 2009-05
- Completion
- 2009-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nepadutant | Protein / enzyme biologic | 0.1 mg/kg | Oral |
| Subject | Nepadutant | Protein / enzyme biologic | 0.5 mg/kg | Oral |
Indications
No indication recorded.